InsiderTrades

Form 4 for GILD Gilead Sciences

Accepted 2021-08-12 00:00:00 ET · period of report 2021-08-10 · accession 0001127602-21-023570 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-08-12 2021-08-10 GILD Wilfong Diane E. SVP, CAO, Ctrl F - Tax $69.24 -907 20.4K -4% -$62.8K
D 2021-08-12 2021-08-10 GILD Wilfong Diane E. SVP, CAO, Ctrl M - OptEx — +2,480 21.3K +13% —
D 2021-08-12 2021-08-10 GILD Wilfong Diane E. SVP, CAO, Ctrl M - OptEx — -2,480 15.9K -13% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-08-10 F D 907 $69.24 20,398 D — —
2 Common Common Stock 2021-08-10 M A 2,480 — 21,305 D — — (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
3 Derivative Restricted Stock Unit 2021-08-10 M D 2,480 — 15,907 D — · — to — 2,480 Common Stock (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested.